We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Says Hatch-Waxman Patent Infringement Suits Are Not Antitrust Proof
FTC Says Hatch-Waxman Patent Infringement Suits Are Not Antitrust Proof
The Federal Trade Commission filed an amicus brief in the case of Takeda v. Zydus, urging the U.S. District Court of New Jersey to reject the notion that patent infringement suits brought under a law governing generic drugs are exempt from antitrust scrutiny.